摘要
近年来,中医在传染性非典型性肺炎(SARS)、甲型H1N1流感(甲流)等新型突发传染病的防治方面发挥了巨大的作用。新型冠状病毒肺炎(COVID-19)的流行,又给人类的健康及社会稳定带来新的威胁。结合SARS、甲流的防治经验和COVID-19现有病例资料及文献,该文从病因、五运六气、病证特点、辨证论治等方面,浅析3种疫病的异同。SARS病因属"热毒",病机可见"热毒、瘀血、气阴两伤",治疗以清热解毒祛邪为主;甲流属"寒疫",病机为风寒疫毒挟湿,治则以扶阳顾津、解表散寒、化饮祛湿为主;COVID-19属"湿毒",故病机为"湿、毒、虚、瘀、风",治疗以宣肺祛湿透邪为主。结合中医对既往传染性疾病的认识和防治经验,以及中国临床COVID-19治愈患者资料,为全国人民深入了解和应对COVID-19提供策略,以期完善COVID-19防治方案,发挥中医药在突发公共卫生事件中的作用。
In recent years,Chinese medicine has played a huge role in the prevention and treatment of new and sudden infectious diseases such as SARS and influenza A H1N1.Since the prevalence of new corona virus disease(COVID-19),it has brought new threats to human health and social stability.Combining the experiences of SARS and influenza A H1N1 prevention and treatment,and the case data and literature of COVID-19,the similarities and differences among the three diseases in terms of causes,five movements and six Qi,characteristics,dialectical mode and treatment were analyzed.The SARS was a heatpoison plague,with the pathogenesis of heat poison,stasis,and Qi and Yin deficiency.So the treatment principle was mainly clearing away heat,and expelling evil.The influenza A H1N1 was a cold plague,with the pathogenesis of wind-cold poison combined with wet evil.The Treatment of influenza A H1N1 was mainly supplying Yang and fluid,resolving the exterior and dissipating cold,and resolving dampness.And for COVID-19,a wet-poison plague,its pathogenesis was"wet,poison,weakness,stasis,and wind".So the basic treatment was declaring lung and removing dampness.Combined with TCM understanding and experience of SARS and influenza A H1N1 prevention and treatment,and through the analysis and comparison,we try to provide clinical theory for people to understand and respond to COVID-19.To improve COVID-19 prevention and treatment regime and give full play to the role of traditional Chinese medicine in public health emergencies.
作者
刘丽婷
李杰
彭桂英
吴童
黄明明
于子洋
赵翠云
LIU Liting;LI Jie;PENG Guiying;WU Tong;HUANG Mingming;YU Ziyang;ZHAO Cuiyun(Beijing University of Chinese Medicine,Beijing 100029,China;Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China)
出处
《辽宁中医药大学学报》
CAS
2021年第1期208-212,共5页
Journal of Liaoning University of Traditional Chinese Medicine
基金
北京中医药大学基本科研业务费创新科研团队项目(2019-JYB-TD014)。